Dexmedetomidine as Neuroanesthesia Management in Patient with Meningioma Craniotomy

Mohammad Aji Kumoro, MM Rudi Prihatno, Aditya Pradana Kartinofan


Meningiomas are the type of tumour that grows from the protective membranes of the brain, which line both the brain and spinal cord. The incidence rate of meningioma between females and males is 2:1 and tt is a fairly common neurosurgical case at Margono Soekarjo General Hospital Purwokerto. Dexmedetomidine is the drug of choice used for sedation and analgesia. In various literature, it is said that the use of dexmedetomidine will reduce hemodynamic fluctuations during surgery. A 49-year-old man was hospitalized because of cephalgia and hemiparesis of his left extremity. Computed tomography scan revealed a solid tumour at parietooccipitalis region, lobulated, measuring 7,2 x 7,1 x 4,4 cm, and an increase in intracranial pressure. General anesthesia was administered, beginning with premedication using sufentanil for analgesia, followed by induction with thiopental, and rocuronium for muscle relaxation to facilitate intubation. Dexmedetomidine is an attractive option available for anesthesiologist for maintaining general anesthesia. In this surgical procedure to remove an intracranial tumor, appropriate induction and monitoring of the patient's condition during surgery is required to prevent the risk of increasing intracranial pressure. Dexmedetomidine reduces cerebral blood flow, decreases intracranial pressure, reduces the rate of cerebral oxygen metabolism, and maintains cerebral perfusion pressure. Good management of neuroanesthesia supports the maintenance of hemodynamic stability and leads to better outcomes in craniotomy surgery. Dexmedetomidine has benefits on maintenance of anaesthesia in neurosurgical procedures.


Meningioma, dexmedetomidine, anaesthesia management

Full Text:



Dube SK, Pandia MP, Chaturvedi A, Bithal P, Dash HH. Comparison of intraoperative brain condition, hemodynamics and postoperative recovery between desflurane and sevoflurane in patients undergoing supratentorial craniotomy. J Saudi Anaesth. 2015;9(2): 167–73. Doi: 10.4103/1658-354X.152866

Bisri DY, Bisri T. Dasar-Dasar Neuroanestesi.. Faculty of Medicine, Padjadjaran University. Bandung. 2019.

Butterworth JF, Mackey DC, Wasnick JD. Morgan and Mikhail's Clinical Anesthesiology. New York: Mc Graw Hill. 2007.

Gropper MA, Eriksson LI, Fleisher LA, Leslie K, Wiener-Kronish JP, Cohen NH, et al. editors, Miller’s Anesthesia. 9th ed. Elsevier Inc. 2020.

Zhou Z, Ying M, Zhao R. Efficacy and safety of sevoflurane vs propofol in combination with remifentanil for anesthesia maintenance during craniotomy. Medicine. 2021; 100(51): 1–8. Doi: 10.1097/MD.0000000000028400

Permatasari E, Suarjaya IPP, Saleh SC, Wargahadibrata AH. Penggunaan dexmedetomidin untuk operasi meningioma petroclival dengan intraoperatif neurophysiological monitoring. J neuroanestesi Indonesia. 2017; 6 (1): 34-41. Doi:

Gracia CJ, Hanafie A, and Nasution AH. Comparison of hemodynamic response between propofol and thiopental as an induction agent in neurosurgery anesthesia at Haji Adam Malik General Hospital Medan- Indonesa. Bali Med J. 2018;7(3):717–22

Kulsum, Suryadi T. Neuro-anesthetic management of craniotomy-surgery in removal tumor multiple meningioma patients: A case report. Open Access Macedonian J Med Sci. 2021;9(C):146–50

Nguyen A, Mandavalli A, Diaz MJ, Root KT, Patel A, Casauay J, et al. Neurosurgical anesthesia: Optimizing outcomes with agent selection. Biomedicines. 2023; 11(2): 372. Doi: 10.3390/biomedicines11020372

Su S, Ren C, Zhang H, Liu Z, Zhang Z. The Opioid-Sparing effect of perioperative dexmedetomidine plus sufentanil infusion during neurosurgery: a retrospective study. Front Pharmacol. 2016;7:407.



  • There are currently no refbacks.



JNI is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License